95627 ⎘
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or - in which the condensed system contains four or more hetero rings
RAS INHIBITORS
#2MEMBRANE-ASSOCIATED TYROSINE AND THREONINE KINASE INHIBITOR AND USE THEREOF
#3TRICYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER
#4IMIDAZOPYRIDINE DERIVATIVES WITH BICYCLIC STRUCTURE
#5ORGANIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC EQUIPMENT INCLUDING THE ELECTRONIC APPARATUS
#6Macrocyclic Compounds as RAS Inhibitors
#7RAS INHIBITORS
#8RAS INHIBITORS
#9SOMATOSTATIN RECEPTOR 2 AGONISTS AND USES THEREOF
#10MACROCYCLIC RAS INHIBITORS
#11MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#12MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#13RAS INHIBITORS
#14RAS INHIBITORS
#15TRICYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER
#16RAS INHIBITORS
#17INDAZOLE CONTAINING MACROCYCLES AND THEIR USE
#18INHIBITORS OF KIF18A AND USES THEREOF
#19HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS
#20MACROCYCLIC COMPOUNDS AND METHODS OF USE
#21MACROCYCLIC INHIBITORS OF KRAS FOR THE TREATMENT OF CANCER
#22ORGANIC MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE USING THE SAME
#23MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#24MACROCYCLIC COMPOUNDS AND METHODS OF USE
#25USE OF SECOND NEAR-INFRARED ORGANIC FLUORESCENT COMPOUND IN PREPARATION OF BIOIMAGING CONTRAST AGENT AND IN VASCULAR FLUORESCENCE IMAGING
#26HALOINDOLE MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER
#27RAS INHIBITORS
#28MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#29MCL1 INHIBITORS
#30MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER
#31RAS INHIBITORS
#32RAS INHIBITORS
#33BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF
#34INHIBITORS OF KRAS
#35ORGANIC COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE USING THE SAME
#36Visibly Transparent, Ultraviolet-Absorbing and Near-Infrared-Absorbing Photovoltaic Devices
#37IMIDAZOPYRIMIDINES AS EED INHIBITORS AND THE USE THEREOF
#38Tricyclic compounds for the treatment of cancer
#39ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT
#40AZAINDAZOLE MACROCYCLE COMPOUNDS AND USES THEREOF
#41KRAS G12D INHIBITORS AND USES THEREOF
#42SYNTHESIS OF RAS INHIBITORS
#43Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators
#44CRYSTALLINE FORMS OF RAS INHIBITORS, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USE THEREOF
#45HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS
#46NOVEL MACROCYCLIC AMINOPYRAZOLE COMPOUNDS AS CDK2 INHIBITORS
#47MACROCYCLIC COMPOUNDS AND METHODS OF USE
#48MACROCYCLIC 2-ALLYLTETRAHYDROFURANS AS INHIBITORS OF MCL-1
#49MACROCYCLIC TLR7 AGONIST, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF
#50NEAR-INFRARED ORGANIC SMALL MOLECULE WITH VINYL GROUPS AND ACTIVE LAYER MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE USING THE SAME
#51MACROCYCLIC SPIROCYCLE DERIVATIVES AS MCL-1 INHIBITORS
#52METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND
#53NOVEL COMPOUND, PREPARATION METHOD THEREOF, AND ANTIBIOTIC COMPOSITION COMPRISING SAME
#54ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
#55TYK2 PSEUDOKINASE LIGANDS
#56Process of making CFTR modulators
#57MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS
#58RAS INHIBITORS
#59MCL1 inhibitors
#60Bridged tricyclic carbamoylpyridone compounds and uses thereof
#61Bridged tricyclic carbamoylpyridone compounds and uses thereof
#62Organic semiconductor mixture and organic optoelectronic device containing the same
#63CRYSTALLINE FORMS OF CFTR MODULATORS
#64TERNARY PHOTOACTIVE LAYER COMPOSITION AND ORGANIC SOLAR CELL COMPRISING SAME
#65IMMUNOMODULATORS
#66MACROCYCLIC COMPOUNDS AND USES THEREOF
#67Heteroaromatic macrocyclic ether chemotherapeutic agents
#68RAS INHIBITORS
#69CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE
#70Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof
#71MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#72NITROGEN-CONTAINING SPIRAL ORGANIC COMPOUND AND APPLICATION THEREOF IN ORGANIC LIGHT-EMITTING DEVICE AND PANEL
#73LIGHT-EMITTING DEVICE INCLUDING FUSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE FUSED CYCLIC COMPOUND
#74FUSED HETEROCYCLE DERIVATIVES
#75Imidazopyrimidines as EED inhibitors and the use thereof
#76Method for producing cyclic imide compound, composition, and compound
#77TYK2 pseudokinase ligands
#78HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12C
#79Fused heterocyclic compounds as RET kinase inhibitors
#80Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
#81MACROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASE
#82COMPOUND, PRODUCTION METHOD THEREFOR, AND ORGANIC SEMICONDUCTOR MATERIAL OBTAINED USING SAID COMPOUND
#83CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE
#84CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE
#85SPECIFIC CONJUGATION LINKERS, SPECIFIC IMMUNOCONJUGATES THEREOF, METHODS OF MAKING AND USES SUCH CONJUGATES THEREOF
#86Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof
#87Infrared absorbers, infrared absorbing/blocking films and photoelectric devices and organic sensors and electronic devices
#88Heterocyclic systems and pharmaceutical compositions thereof
#89MCL1 inhibitors
#90Ras inhibitors
#91Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof
#92Process of making CFTR modulators
#93Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof
#94NOVEL HETEROCYCLIC SYSTEMS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#95Heterocyclic systems and pharmaceutical applications thereof
#96Substituted pyrazino[1′,2′:1,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment
#97Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
#98Visibly Transparent, Ultraviolet-Absorbing and Near-Infrared-Absorbing Photovoltaic Devices
#99Organic semiconducting compounds
#100Organic semiconducting compounds
#101Fused polycyclic heteroaromatic compound, organic thin film including compound and electronic device including organic thin film
#102Antimicrobial agents and the method of synthesizing the antimicrobial agents
#103Merocyanine-based compounds, and dyes, kits and contrast medium compositions for labelling biomolecules comprising the same
#104Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
#105SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
#106Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectronic applications
#107MACROCYLIC PYRIDINE DERIVATIVES
#108Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
#109Benzothiazole macrocycles as inhibitors of human immunodeficiency virus replication
#110Red-shifted luciferins and methods of using same
#111Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment
#112Macrocyclic compounds as protein kinase inhibitors
#113Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#114Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
#115NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS
#116Electronic device comprising metal complexes
#117Inhibitors of human immunodeficiency virus replication
#118Spiroimidazolone derivative
#119Macrocyclic compounds as IRAK4 inhibitors for the treatment of inflammatory diseases
#120Inhibitors of human immunodeficiency virus replication
#121Conjugated polymers
#1222-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators
#123Materials for organic electroluminescent devices
#124Red-shifted luciferins and methods of using same
#125Macrocyclic compounds as protein kinase inhibitors
#126Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
#127Chemical compounds 542
#128Substituted imidazo[1,2-a]imidazo[4′,5′:4,5]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections
#129Thiadiazole, compound for light-emitting elements, light-emitting element, light-emitting apparatus, authentication apparatus, and electronic device
#130Macrocyclic indole derivatives useful as hepatitis C virus inhibitors
#131Polymer compound and electronic device using the same
#132GAMBOGIC ACID CYCLIZATION ANALOGUES, THEIR PREPARATION METHOD AND APPLICATION THEREOF
#133Bridged triarylamines and -phosphines as materials for electronic devices
#134Materials for organic electroluminescent devices
#135Spiro-oxindole compounds and their uses as therapeutic agents
#136Spiroimidazolone derivative
#137Nitrogen-containing condensed heterocyclic compounds for OLEDs
#138METHOD FOR TREATING CHRONIC PAIN
#139NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#140RING COMPOUND
#141TRICYCLIC SPIRO-OXINDOLE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS
#142THIOPEPTIDE PRECURSOR PROTEIN, GENE ENCODING IT AND USES THEREOF
#143Macrocyclic indole derivatives useful as hepatitis C virus inhibitors
#144TETRACYCLIC INDOLE DERIVATIVES AND THEIR USE FOR TREATING OR PREVENTING VIRAL INFECTIONS
#145Electronic device comprising metal complexes
#146CYCLIC COMPOUNDS AND THE USE THEREOF AS LIGHT ABSORBERS, LIGHT EMITTERS, OR COMPLEX LIGANDS
#147TUNABLE PHENYLACETYLENE HOSTS
#148POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS
#149Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
#150TRICYCLIC SPIRO-OXINDOLE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS
#151Spiro-oxindole compounds and their use as therapeutic agents
#152Antibacterial compounds and processes for its production
#153Method for producing organic electronic device including converting a precursor for a semiconductor layer
#154Rigidized trimethine cyanine dyes
#155Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors
#156Macrocycles and their uses
#157Therapeutic compounds
#158Tunable phenylacetylene hosts
#159Antimicrobial photoinactivation using chalcogen analogs of benzo(A)phenoxazinium dyes
#160Rigidized trimethine cyanine dyes
#161Rifamycin analogs and uses thereof
#162Production method of fluorinated purine nucleoside derivative, intermediate therefor and production method thereof
#163ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC ELECTRONIC DEVICE
#164Macroheterocyclic compounds as kinase inhibitors
#165Porphyrin derivatives
#1668-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
#167GM-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent
#168Cyclic compounds and the use thereof as light absorbers, light emitters, or complex ligands
#169Rifamycin analogs and uses thereof
#170Heteroaromatic macrocyclic ether chemotherapeutic agents
#171Spirooxindole-pyrrolothiazole heterocyclic hybrids